In this engaging discussion, Adam Laing, Co-founder and Chief Scientific Officer of IMU Biosciences, shares how his company uses AI to decode the immune system. He explains the innovative technology behind measuring 80 million data points from blood samples, enabling personalized insights into health. The conversation highlights the potential of predictive immune profiling in tailoring treatments for diseases like cancer and autoimmune disorders. Laing also emphasizes the power of collaboration among multidisciplinary teams to drive breakthroughs in precision medicine.